Adverse Cardiovascular Effects from the Use of Anabolic-Androgenic Steroids as Ergogenic Resources

REFERENCES

• Achar, S., Rostamian, A., & Narayan, S. M. (2010). Cardiac and metabolic effects of anabolic-androgenic steroid abuse on lipids, blood pressure, left ventricular dimensions, and rhythm. The American Journal of Cardiology, 106(6), 893–901.
   PubMed Web of Science ®Google Scholar
• ACSM. (1987). Position stand on the use of anabolic- androgenic steroids in sports. Medicine and Science in Sports and Exercise, 19(5), 534-539.
   Web of Science ®Google Scholar
• Alves, M. J. N. N., Dos Santos, M. R., Dias, R. G., Akiho, C. A., Laterza, M. C., Rondon, M. U. P. B., … Negrāo, C. E. (2010). Abnormal neurovascular control in anabolic androgenic steroids users. Medicine and Science in Sports and Exercise, 42(5), 865–871.
   PubMed Web of Science ®Google Scholar
• Angell, P., Chester, N., Green, D., Somauroo, J., Whyte, G., & George, K. (2012). Anabolic steroids and cardiovascular risk. Sports Medicine, 42(2), 119–134.
   PubMed Web of Science ®Google Scholar
• Cunha, T. S., Moura, M. J. C. S., Bernardes, C. F., Tanno, A. P., & Marcondes, F. K. (2005). Vascular sensitivity to phenylephrine in rats submitted to anaerobic training and nandrolone treatment. Hypertension, 46(4), 1010–1015.
   PubMed Web of Science ®Google Scholar
• Delgado, J., Saborido, A., & Megías, A. (2010). Prolonged treatment with the anabolic-androgenic steroid stanozolol increases antioxidant defences in rat skeletal muscle. Journal of Physiology and Biochemistry, 66(1), 63–71.
   PubMed Web of Science ®Google Scholar
• Dickerman, R. D., Schaller, F., Prather, I., & McConathy, W. J. (1995). Sudden cardiac death in a 20-year-old bodybuilder using anabolic steroids. Cardiology, 86(2), 172–173.
   PubMed Web of Science ®Google Scholar
• Do Carmo, E. C., Fernandes, T., Koike, D., Da Silva, N. D., Mattos, K. C., Rosa, K. T., … de Oliveira, E. M. (2011). Anabolic steroid associated to physical training induces deleterious cardiac effects. Medicine and Science in Sports and Exercise, 43(10), 1836–1848.
   PubMed Web of Science ®Google Scholar
• Far, H. R. M., Ågren, G., & Thiblin, I. (2012). Cardiac hypertrophy in deceased users of anabolic androgenic steroids: An investigation of autopsy findings. Cardiovascular Pathology: The Official Journal of the Society for Cardiovascular Pathology, 21(4), 312–316.
   PubMed Web of Science ®Google Scholar
• Freeman, E. R., Bloom, D. A., & McGuire, E. J. (2001). A brief history of testosterone. The Journal of Urology, 165(2), 371–373.
   PubMed Web of Science ®Google Scholar
• Gårevik, N., Skogastierna, C., Rane, A., & Ekström, L. (2012). Single dose testosterone increases total cholesterol levels and induces the expression of HMG CoA reductase. Substance Abuse Treatment, Prevention, and Policy, 7(1), 12–17.
   PubMedGoogle Scholar
• Golestani, R., Slart, R. H. J. a, Dullaart, R. P. F., Glaudemans, A. W. J. M., Zeebregts, C. J., Boersma, H. H., … Dierckx, R. A. (2012). Adverse cardiovascular effects of anabolic steroids: Pathophysiology imaging. European Journal of Clinical Investigation, 42(7), 795–803.
   PubMed Web of Science ®Google Scholar
• Grace, F., Sculthorpe, N., Baker, J., & Davies, B. (2003). Blood pressure and rate pressure product response in males using high-dose anabolic androgenic steroids (AAS). Journal of Science and Medicine in Sport / Sports Medicine Australia, 6(3), 307–312.
   PubMed Web of Science ®Google Scholar
• Graham, M. R., Grace, F. M., Boobier, W., Hullin, D., Kicman, A, Cowan, D., … Baker, J. S. (2006). Homocysteine induced cardiovascular events: A consequence of long term anabolic-androgenic steroid (AAS) abuse. British Journal of Sports Medicine, 40(7), 644–648.
   PubMed Web of Science ®Google Scholar
• Hartgens, F. (2004). Effects of androgenic-anabolic steroids on apolipoproteins and lipoprotein (a). British Journal of Sports Medicine, 38(3), 253–259.
   PubMed Web of Science ®Google Scholar
• Hartgens, Fred, & Kuipers, H. (2004). Effects of androgenic-anabolic steroids in athletes. Sports Medicine, 34(8), 513–554.
   PubMed Web of Science ®Google Scholar
• Hoberman, J. M., & Yesalis, C. E. (1995). The history of synthetic testosterone. Scientific American, 272(2), 76–81.
   PubMed Web of Science ®Google Scholar
• Iliescu, R., & Reckelhoff, J. F. (2006). Testosterone and vascular reactivity. Clinical Science, 111(4), 251–252.
   Web of Science ®Google Scholar
• Isidori, A. M., Giannetta, E., Greco, E. A, Gianfrilli, D., Bonifacio, V., Isidori, A., … Fabbri, A. (2005). Effects of testosterone on body composition, bone metabolism and serum lipid profile in middle-aged men: A meta-analysis. Clinical Endocrinology, 63(3), 280–293.
   PubMed Web of Science ®Google Scholar
• Kochakian, C. D., & Welder, A. A. (1993). Anabolic-androgenic steroids: In cell culture. In Vitro Cellular & Developmental Biology. Animal, 29A(6), 433–438.
   PubMed Web of Science ®Google Scholar
• Krieg, A., Scharhag, J., Albers, T., Kindermann, W., & Urhausen, A. (2007). Cardiac tissue Doppler in steroid users. International Journal of Sports Medicine, 28(8), 638–643.
   PubMed Web of Science ®Google Scholar
• Lane, H. A., Grace, F., Smith, J. C., Morris, K., Cockcroft, J., Scanlon, M. F., & Davies, J. S. (2006). Impaired vasoreactivity in bodybuilders using androgenic anabolic steroids. European Journal of Clinical Investigation, 36(7), 483–488.
   PubMed Web of Science ®Google Scholar
• Luijkx, T., Velthuis, B. K., Backx, F. J. G., Buckens, C. F. M., Prakken, N. H. J., Rienks, R., … Cramer, M. J. (2013). Anabolic androgenic steroid use is associated with ventricular dysfunction on cardiac MRI in strength trained athletes. International Journal of Cardiology, 167(3), 664–668.
   PubMed Web of Science ®Google Scholar
• Marcon, D., Graça, A. B. D. S., & Nascimento, J. V. Do. (2012). Práticas pedagógicas como cenário para a construção do conhecimento pedagógico do conteúdo dos futuros professores de Educação Física. Revista da Educação Física/UEM, 23(2), 307–318.
   Google Scholar
• Mortensen, C., Andersen, O., Krag, A., Bendtsen, F., & Møller, S. (2012). High-sensitivity C-reactive protein levels predict survival and are related to haemodynamics in alcoholic cirrhosis. European Journal of Gastroenterology & Hepatology, 24(6), 619–626.
   PubMed Web of Science ®Google Scholar
• Nascimento, J. H. M., & Medei, E. (2011). Cardiac effects of anabolic steroids: Hypertrophy, ischemia and electrical remodelling as potential triggers of sudden death. Mini Reviews in Medicinal Chemistry, 11(5), 425–429.
   PubMed Web of Science ®Google Scholar
• Nieminen, M. S., Rämö, M. P., Viitasalo, M., Heikkilä, P., Karjalainen, J., Mäntysaari, M., & Heikkilä, J. (1996). Serious cardiovascular side effects of large doses of anabolic steroids in weight lifters. European Heart Journal, 17(10), 1576–1583.
   PubMed Web of Science ®Google Scholar
• Pärssinen, M., & Seppälä, T. (2002). Steroid use and long-term health risks in former athletes. Sports Medicine, 32(2), 83–94.
   PubMed Web of Science ®Google Scholar
• Pey, A., Saborido, A., Blázquez, I., Delgado, J., & Megías, A. (2003). Effects of prolonged stanozolol treatment on antioxidant enzyme activities, oxidative stress markers, and heat shock protein HSP72 levels in rat liver. The Journal of Steroid Biochemistry and Molecular Biology, 87(4–5), 269–277.
   PubMed Web of Science ®Google Scholar
• Rocha, F. L., Carmo, E. C., Roque, F. R., Hashimoto, N. Y., Rossoni, L. V, Frimm, C., … Oliveira, E. M. (2007). Anabolic steroids induce cardiac renin-angiotensin system and impair the beneficial effects of aerobic training in rats. American Journal of Physiology. Heart and Circulatory Physiology, 293(6), H3575–H3583.
   PubMed Web of Science ®Google Scholar
• Sader, M. A., Griffiths, K. A., Skilton, M. R., Wishart, S. M., Handelsman, D. J., & Celermajer, D. S. (2003). Physiological testosterone replacement and arterial endothelial function in men. Clinical Endocrinology, 59(1), 62–67.
   PubMed Web of Science ®Google Scholar
• Santamarina, R. (2008). Ischemic stroke related to anabolic abuse. Clinical Neuropharmacology, 31(2), 80–85. Retrieved from http://journals.lww.com/clinicalneuropharm/Abstract/2008/030 00/Ischemic_Stroke_Related_to_Anabolic_Abuse.3.aspx
   PubMed Web of Science ®Google Scholar
• Santos, A. M, Rocha, M., & Silva, M. (2011). Illicit use and abuse of anabolic-androgenic steroids among brazilian bodybuilders. Substance Use & Misuse, 46, 724–748.
   Web of Science ®Google Scholar
• Shakhmatova, O. O., Komarov, A. L., & Panchenko, E. P. (2010). Disturbances of homocysteine metabolism as a risk factor of cardiovascular diseases development: Effect on prognosis and possibilities of correction with drugs. Kardiologiia, 50(1), 42–50.
   PubMed Web of Science ®Google Scholar
• Shimada, Y., Yoritaka, A., Tanaka, Y., Miyamoto, N., Ueno, Y., Hattori, N., & Takao, U. (2012). Cerebral infarction in a young man using high-dose anabolic steroids. Journal of Stroke and Cerebrovascular Diseases: The official journal of National Stroke Association, 21(8), 906.e9–906.e11.
   Web of Science ®Google Scholar
• Silva, L. S. M. F., & Moreau, R. L de Moraes. (2003). Uso de esteróides anabólicos androgênicos por praticantes de musculação de grandes academias da cidade de São Paulo. Revista Brasileira de Ciências Farmacêuticas, 39(3), 327–333.
   Google Scholar
• Silva, P., Machado, L., Figueredo, V., Cioffi, A., Prestes, M., & Czepielewski, M. A. (2007). Prevalence of the use of anabolic agents among strength training apprentices in Porto Alegre, RS. Arquivos Brasileiros de Endocrinologia e Metabologia, 51(1), 104–110.
   PubMed Web of Science ®Google Scholar
• Soares, J. M., & Duarte, J. A. (1991). Effects of training and an anabolic steroid on murine red skeletal muscle. A stereological analysis. Acta Anatomica, 142(2), 183–187.
   PubMedGoogle Scholar
• Soci, U. P. R., Redondo, F. R. R., Fernandes, T., Angelis, K., Irigoyen, M. C., Coelho, M., & Oliveira, E. M. (2009). Esteroide anabolizante inibe a angiogênese induzida pelo treinamento físico de natação em músculo sóleo de ratos normotensos. Revista Brasileira de Educação Física e Esporte, 23(3), 195–209.
   Google Scholar
• Thiblin, I., Lindquist, O., & Rajs, J. (2000). Cause and manner of death among users of anabolic androgenic steroids. Journal of Forensic Sciences, 45(1), 16–23.
   PubMed Web of Science ®Google Scholar
• Turillazzi, E., Perilli, G., Di Paolo, M., Neri, M., Riezzo, I., & Fineschi, V. (2011). Side effects of AAS abuse: An overview. Mini Reviews in Medicinal Chemistry, 11(5), 374–389.
   PubMed Web of Science ®Google Scholar
• Urhausen, A. (2004). Are the cardiac effects of anabolic steroid abuse in strength athletes reversible? Heart, 90(5), 496–501.
   PubMed Web of Science ®Google Scholar
• Vanberg, P., & Atar, D. (2010). Androgenic anabolic steroid abuse and the cardiovascular system. Handbook of Experimental Pharmacology, 195, 411–457.
   Google Scholar
• Velasco, L., Sánchez, M., Rubín, J. M., Hidalgo, A., Bordallo, C., & Cantabrana, B. (2002). Intracellular cAMP increases during the positive inotropism induced by androgens in isolated left atrium of rat. European Journal of Pharmacology, 438(1–2), 45–52.
   PubMed Web of Science ®Google Scholar
• Weber, K. T., & Brilla, C. G. (1991). Pathological hypertrophy and cardiac interstitium. Fibrosis and renin-angiotensin-aldosterone system. Circulation, 83(6), 1849–1865.
   PubMed Web of Science ®Google Scholar
• Whitsel, E. A., Boyko, E. J., Matsumoto, A. M., Anawalt, B. D., & Siscovick, D. S. (2001). Intramuscular testosterone esters and plasma lipids in hypogonadal men: A meta-analysis. The American Journal of Medicine, 111(4), 261–269.
   PubMed Web of Science ®Google Scholar
• Wysoczanski, M., Rachko, M., & Bergmann, S. (2008). Acute myocardial infarction in a young man using anabolic steroids. Angiology, 59(3), 376–378. Retrieved January 16, 2013, from http://ang.sagepub.com/content/59/3/376.short
   PubMed Web of Science ®Google Scholar
• Yesalis, C. E. (2001). Use of steroids for self-enhancement: An epidemiologic/societal perspective. The AIDS Reader, 11(3), 157–160.
   PubMedGoogle Scholar
• Yokoyama, T., Nakano, M., Bednarczyk, J. L., McIntyre, B. W., Entman, M., & Mann, D. L. (1997). Tumor necrosis factor-alpha provokes a hypertrophic growth response in adult cardiac myocytes. Circulation, 95(5), 1247–1252.
   PubMed Web of Science ®Google Scholar